-
Mashup Score: 0Impact of Medicare Part D Changes on Access to Care for Patients with Cancer – [Podcast] Ep 168 - 1 day(s) ago
In this episode, Lindsey Greenleaf, JD, MBA, leader in federal and state policy at ADVI Health and Pam Traxel, senior VP of alliance development and philanthropy at American Cancer Society, Cancer Action Network, discuss the impact of policy updates.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet
-
Mashup Score: 0A Practice Within a Practice: Integrating Oncodermatology into Comprehensive Cancer Care – [Video Podcast] Ep 49 - 14 day(s) ago
Dr. Heberton sheds light on issues of access for patients with cancer seeking dermatologic expertise.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet-
🎧 "A Practice Within a Practice: Integrating #Oncodermatology into Comprehensive Cancer Care" Dr. Meghan Heberton discusses managing dermatologic adverse events, the need for specialized care and communication. Listen now! https://t.co/VI2oTUH5gT #onctwitter #immunotherapy https://t.co/4KJxxHUCPZ
-
-
Mashup Score: 1
Genetic testing and molecular profiling can be the key to better outcomes for patients with pancreatic cancer by allowing oncologists to implement more targeted therapies.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet-
Genetic testing and molecular profiling can give patients with #PancreaticCancer the chance to significantly improve their treatment outcomes. Read how providers can ensure that all patients with this cancer have awareness of and access to these 2 tests👉 https://t.co/xkf5r0torc https://t.co/pdjNrLnXYI
-
-
Mashup Score: 1The Power of Serial Molecular Residual Disease Assessment to Inform Treatment Decisions in Colorectal Cancer | Oncology Issues - 16 day(s) ago
Can’t sign in? Forgot your username? Can’t sign in? Forgot your password? Oncology Issues, 2024;39(5):44–47 Circulating tumor DNA (ctDNA) is a powerful tool in cancer diagnostics that can be measured to assess the presence or absence of molecular residual disease (MRD) in a patient’s blood. Natera, an industry leader in cell-free DNA technology, was an early pioneer of MRD testing, launching Signatera in 2019 1; the test has now been validated in thousands of patients across multiple tumor types. 1–6
Source: journals.healio.comCategories: General Medicine News, NursingTweet-
The newest installment of Oncology Issues is here! Read it now to learn about Natera’s Signatera test and its effectiveness in predicting disease recurrence and chemotherapy benefits, thus significantly improving patient outcomes: https://t.co/GhX6DkhZVz.
-
-
Mashup Score: 3Sarcoma Resources for Providers and Patients - 17 day(s) ago
Explore carefully curated resources designed to enhance and support sarcoma cancer care. Resources are available for patients, caregivers, health care providers, social workers, patient advocates, and all members of the multidisciplinary care team.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet-
We’re proud to partner with the @CureSarcoma to share vital resources for sarcoma care. Find clinical trial info, sarcoma subtype education, caregiver support, and more! Together, we can enhance sarcoma care. 💛 Learn more: https://t.co/Pslz9a3VtN. #sarcoma #onctwitter https://t.co/G9VHqki9Ft
-
-
Mashup Score: 1Technology-Enabled Assessments Support Remote Care of Oncology Patients and Improve the Care Team Experience | Oncology Issues - 17 day(s) ago
Can’t sign in? Forgot your username? Can’t sign in? Forgot your password? Oncology Issues, 2024;39(5):35–43 Oncology researchers have significant evidence documenting the consequences of febrile neutropenia; these and other fever experiences can lead to significant morbidity and mortality. Acute care costs from malignant crises and sepsis events can be significant and burdensome. 1 Approximately 50% of patients with febrile neutropenia will develop an infection, of which 20% with profound neutropenia will
Source: journals.healio.comCategories: General Medicine News, NursingTweet-
Read the latest Oncology Issues for a feasibility study that demonstrated patients’ & providers’ willingness to engage with innovative technologies to gain new insights into oncology patients at risk of experiencing febrile neutropenia & other fever events https://t.co/eMtqsbNeaw https://t.co/KT8a7IBVtz
-
-
Mashup Score: 0Live from the NOC Gala - 18 day(s) ago
CANCERBUZZ speaks with guests at the 2024 NOC Gala event about what they are looking for at the conference.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet-
We kicked off this year’s #ACCCNOC with an unforgettable 50th-anniversary gala! In episode #5 of our Live from NOC series, #CancerBuzz speaks with guests at the event as they share their past experiences with ACCC and hopes for the future. Listen: https://t.co/bretmzjOze. https://t.co/2QHj4c9PWp
-
-
Mashup Score: 0Citrus Oncology: Optimizing Cancer Care by Managing Side Effects Oncology Services | Oncology Issues - 18 day(s) ago
Can’t sign in? Forgot your username? Can’t sign in? Forgot your password? Oncology Issues, 2024;39(5):19–28 The earliest written description of cancer dates to 3000 BC, immortalized in the Edwin Smith Papyrus, an ancient Egyptian textbook on trauma surgery. The parchment describes 8 cases of tumors or ulcers of the breast and its presumed author—a physician named Imhotep—believed there was no treatment for the disease. 1 It was a reasonable con clusion, given how complex cancer care remains more than 5000
Source: journals.healio.comCategories: General Medicine News, NursingTweet-
Managing side effects of cancer treatment is crucial for improving patients’ quality of life and treatment adherence. Learn how Citrus Oncology is bridging care gaps and supporting patients through their cancer journey in the newest Oncology Issues: https://t.co/C04lPWEIK6. https://t.co/MnNgE5AysK
-
-
Mashup Score: 0
CANCERBUZZ speaks with Terry Keys about his NOC session titled Empowering Partnerships: Enhancing Cancer Research Through Patient Advocacy.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet-
🎙️ In episode #4 of our Live from NOC series #CancerBuzz speaks with Terry Keys about the value of including patients in discussions with clinicians & researchers to address their needs beyond treatment, focusing on quality of life after recovery. Listen: https://t.co/zk4g25SfTJ. https://t.co/A2I9olXu3l
-
-
Mashup Score: 0Implementation of a Lung Cancer Screening Program in a Community Setting | Oncology Issues - 19 day(s) ago
Can’t sign in? Forgot your username? Can’t sign in? Forgot your password? Oncology Issues, 2024;39(5):20–28 Lung cancer is the leading cause of cancer mortality in the United States, greater than the deaths from breast, colorectal, and prostate cancers combined. 1 The American Cancer Society (ACS) estimated that 238,340 people would be diagnosed with lung cancer, and 127,070 people would die from this disease in 2023. 1 The lifetime risk of developing lung cancer is approximately 1 in 16 for men and 1 in
Source: journals.healio.comCategories: General Medicine News, NursingTweet-
High mortality rates of lung cancer highlight the need for better screening strategies. Learn about a community screening program that’s boosting early detection and improving outcomes through education in Oncology Issues—out now: https://t.co/d0WjdQpg1d! https://t.co/QlnZ8iN2gD
-
🎙️ New #podcast out now! In this episode, #CancerBuzz speaks with Lindsay Greenleaf about the upcoming $2,000 out-of-pocket Medicare Part D cap in 2025 and Pam Traxel about the benefits and challenges of updating oncologists on the new cap. Listen: https://t.co/AVZ7Egwepf. https://t.co/cHhpBC5lxr